News
The FDA approved a new ketamine (KETARx, PharmaTher) for the treatment of surgical pain management. The FDA previously issued a pair of complete response letters for the application in 2024, citing ...
There remains a need for organizations and stakeholders to develop guidance for prescribing ketamine as a pain treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback